Medplus Health Services (NSE:MEDPLUS) Marketable Securities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDPLUS Medplus Health Services Ltd NSE:MEDPLUS
76 GF Score
Price ₹684.05
GF Value ₹962.53
Valuation Modestly Undervalued
View Full Analysis

What is Medplus Health Services Marketable Securities?

Medplus Health Services NSE:MEDPLUS -1.77% 76 Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:MEDPLUS with a GF Score™ of 76/100 and a GF Value™ of ₹962.53 (Modestly Undervalued).

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Medplus Health Services's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Medplus Health Services's annual Marketable Securities increased from Mar. 2024 (₹738 Mil) to Mar. 2025 (₹3,538 Mil) and increased from Mar. 2025 (₹3,538 Mil) to Mar. 2026 (₹3,940 Mil).

Medplus Health Services  (NSE:MEDPLUS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Medplus Health Services Marketable Securities Related Terms

Medplus Health Services Marketable Securities Historical Data

* Premium members only.

The historical data trend for Medplus Health Services's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medplus Health Services Marketable Securities Chart

Medplus Health Services Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 6,361.17 602.99 738.26 3,537.98 3,940.49

Medplus Health Services Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3,947.67 0.00 3,940.49 0.00
NSE:MEDPLUS
76GF Score
Medplus Health Services Ltd NSE:MEDPLUS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medplus Health Services Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Medplus Health Services (NSE:MEDPLUS) has a Marketable Securities of ₹0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Medplus Health Services and its competitors.
Is Medplus Health Services' Marketable Securities too high?
Medplus Health Services' current Marketable Securities is ₹0 Mil. Overall, Medplus Health Services has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medplus Health Services' Marketable Securities compare to competitors?
Medplus Health Services' Marketable Securities of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Medplus Health Services and its competitors. Medplus Health Services's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medplus Health Services stock overvalued right now?
Based on GuruFocus' analysis, Medplus Health Services (NSE:MEDPLUS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹962.53, compared to a current price of ₹684.05 — trading 28.9% below its estimated fair value. The current Marketable Securities is ₹0 Mil. Medplus Health Services' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Medplus Health Services (NSE:MEDPLUS), the current Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?

Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued. The current stock price of ₹684.05 is trading 28.9% below its estimated GF Value™ of ₹962.53. GuruFocus considers Medplus Health Services to be Modestly Undervalued.

Key valuation signals for NSE:MEDPLUS:

  • Marketable Securities: ₹0 Mil
  • GF Value™: ₹962.53 vs. price of ₹684.05 (28.9% below fair value)
  • GF Score™: 76/100

No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medplus Health Services Business Description

Other Exchanges 543427:India
Address Opposite IDPL Railway Siding Road, Municipal No: 11-6-56, Survey No. 257 & 258/1, Moosapet, Kukatpally, Hyderabad, TG, IND, 500 037
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
76GF Score

Get the complete analysis for NSE:MEDPLUS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹684.05
Price
₹962.53
GF Value